FDA Approved: SOTRADECOL — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved a supplemental application for SOTRADECOL (sodium tetradecyl sulfate) submitted by Mylan Institutional LLC under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Superficial Venous Insufficiency
• Varicose Veins
• Venous Insufficiency

Drugs mentioned

• SOTRADECOL (Sodium tetradecyl sulfate)

Snippet

SUPPL AP for SOTRADECOL (TETRADECYL HYDROGEN SULFATE (ESTER))